Stefan Fest

Stefan Fest

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2011 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
RSRocio Soldati
Rocio Soldati
EBElisa Berger
Elisa Berger
AZAna Zenclussen
Ana Zenclussen
GJGerhard Jorch
Gerhard Jorch
Holger N. LodeHolger N. Lode
Holger N. Lode
SFStefan Fest
Stefan Fest
The immunosuppressive strategies devised by neuroblastoma (NB), the most common solid extracranial childhood cancer, are poorly understood. Here, we identified an immunoevasive program triggered by NB through secretion of galectin‐1 (Gal‐1), a multifunctional glycan‐binding protein. Human and mouse NB cells express and secrete Gal‐1, which negatively regulates T cell and dendritic cell function. When injected subcutaneously in syngeneic A/J mice, knockdown transfectants expressing low amounts of Gal‐1 (NXS2/L) showed reduction of primary tumor growth by 83–90% and prevented spontaneous liver metastases in contrast to NXS2 cell variants (NXS2/H, NXS2 wildtype) expressing high amounts of Gal‐1. Splenocytes from mice receiving Gal‐1 knockdown NXS2/L cells secreted higher amounts of IFN‐γ and displayed enhanced cytotoxic T‐cell function compared to NXS2/H or NXS2 controls. Immunohistochemical analysis revealed a six‐ to tenfold increase in the frequency of CD4+ and CD8+ T cells infiltrating tumors from mice receiving knockdown transfectants. This effect was confirmed by in vitro migration assays. Finally, supernatants of NXS2/H or NXS2 cells suppressed dendritic cell (DC) maturation and induce T cell apoptosis, whereas these effects were only marginal on DCs and T cells exposed to supernatants from NXS2/L cells. These results demonstrate a novel immunoinhibitory role of the Gal‐1‐glycan axis in NB, highlighting an alternative target for novel immunotherapeutic modalities.

15 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
Violeta StojanovskaVioleta Stojanovska
Violeta Stojanovska
SASusanne Arnold
Susanne Arnold
MBMario Bauer
Mario Bauer
HVHermann Voss
Hermann Voss
SFStefan Fest
Stefan Fest
AZAna Zenclussen
Ana Zenclussen
It was postulated that 3D cell culture models more accurately reflect the complex tissue physiology and morphology in comparison to 2D cell monolayers. Currently, there is a shortage of well-characterized and easily maintainable high-throughput experimental models of the human placenta. Here, we characterized three different 3D cultures (e.g., spheroids) derived from trophoblast cell lines and studied their functionality in comparison to primary fetal trophoblasts and placental tissue. The spheroid growth rates of JEG3, BeWo and HTR8/SVneo cell lines were similar among each other and were significantly larger in comparison to primary trophoblast spheroids. All spheroids exhibited migratory properties and shortest distances were registered for JEG3 spheroids. Even though all spheroids displayed invasive capabilities, only the invasive features of HTR8/SVneo spheroids resulted in specific branching. This was in agreement with the invasive properties of the spheroids obtained from primary trophoblasts. Human chorionic gonadotropin production was highest in JEG3 spheroids and only increased when stimulated with cAMP and forskolin in BeWo, but not HTR8/SVneo spheroids. The gene expression analysis confirmed that 3D trophoblast cell cultures and especially HTR8/SVneo spheroids showed considerable similarities with the gene expression profile of primary placental tissue. This study offers a broad characterization of 3D trophoblast spheroids that, in turn, can help in selecting the best model depending on the scientific question that needs to be answered.

23 November 2015 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SFStefan Fest
Stefan Fest
RSRocio Soldati
Rocio Soldati
NCNina M. Christiansen
Nina M. Christiansen
Maria Laura ZenclussenMaria Laura Zenclussen
Maria Laura Zenclussen
JKJana Kilz
Jana Kilz
HCHolger Christiansen
Holger Christiansen
Heme oxygenase (HO)−1 catalyzes the degradation of cytotoxic heme into biliverdin and blocks antitumor immune responses, thus protecting cancer against host defense. Whether this scenario also applies to neuroblastoma (NB), the most common extracranial solid childhood tumor, is not known. Here, we demonstrate for the first time a prognostic relevance of HO‐1 expression in samples from NB patients and show that targeting of HO‐1 prevents both cancer resistance against cellular stress and immune escape in the syngeneic NXS2 A/J mouse model of NB. High HO‐1 RNA expression in NB tissues emerged as unfavorable prognostic marker, in particular for patients older than 18 months as indicated by univariate as well as multivariate survival probability analyses including disease stage and MYCN status. On the basis of this observation we aimed to target HO‐1 by systemic as well as tumor‐specific zinc protoporphyrin‐mediated HO‐1 suppression in a syngeneic immunocompetent NB mouse model. This resulted in 50% reduction of primary tumor growth and a suppression of spontaneous liver metastases. Importantly, HO‐1 inhibition abrogated immune cell paralysis affecting CD4 and CD8 T‐effector cells. This in turn reverted HO‐1‐dependent immune escape mechanisms in NB by increasing NB apoptosis and improved DC maturation. In summary, HO‐1 emerges as a novel immune regulator in NB and emerges as a promising target for the development of therapeutic approaches.

1 June 2021 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
MBMandy Busse
Mandy Busse
ARAnke Redlich
Anke Redlich
RHRoland Hartig
Roland Hartig
SCSerban-Dan Costa
Serban-Dan Costa
HRHenning Rathert
Henning Rathert
AZAna Zenclussen
Ana Zenclussen

1 July 2021 in Cancer Letters
Verified
Journal Article
Closed access
LLLaura Liebscher
Laura Liebscher
CWChristine Weißenborn
Christine Weißenborn
SLStefanie Langwisch
Stefanie Langwisch
BGBjörn-Oliver Gohlke
Björn-Oliver Gohlke
RPRobert Preissner
Robert Preissner
SFStefan Fest
Stefan Fest

1 December 2004 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Holger N. LodeHolger N. Lode
Holger N. Lode
NHNicole Huebener
Nicole Huebener
YZYan Zeng
Yan Zeng
SFStefan Fest
Stefan Fest
SWS Weixler
S Weixler
GGGerhard Gaedicke
Gerhard Gaedicke